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A BST R AC T   
 
Aim:  To determine serum iron, ferritin, folate, and vitamin B12 deficiency and associated hemoglobin (Hb), 
hematocrit (Hct), mean corpuscular volume (MCV), and red cell distribution width (RDW) values in children 
undergoing febrile seizure, and thus to reveal their potential etiological role. 
Method: The serum iron, folate, vitamin B12, and ferritin, and Hb, Hct, MCV, and RDW values of 98 patients 
undergoing FS and presenting to the pediatric neurology department and of 64 control patients were retrieved 
retrospectively and compared. Patient group data were also compared within the group.  
Results: Serum iron, ferritin, and vitamin B12 values were significantly lower in the patient group than in the 
control group. Intragroup comparison revealed higher RDW values in patients with more than three FS and in 
those with complicated seizures.  
Conclusion: This is the first study to investigate the relationship between vitamin B12, folate, and iron 
deficiency and FS. It should be remembered that deficiencies in these micronutrients, which are not routinely 
investigated in patients presenting with FS, may play a role in the etiology, and that the frequency can decrease 
with treatment. It should also not be forgotten that FS patients with high RDW values may be at risk of frequent 
seizure recurrence.  
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Introduction 
Febrile seizure (FS) is an acute, symptomatic 
type of seizure most frequently seen in the first 
five years of childhood and affecting 
approximately 2-5% of children [1,2]. FS has 
been defined as seizures induced by fever in 
children older than one month, with no previous 
history of afebrile seizure, in the absence of any 
central nervous system infection, metabolic or 
electrolyte disorder, intoxication or trauma [3]. 
The American Academy of Pediatrics defines 
the age range at which FS is seen as 6-60 
months [4]. The great majority of FS (65-70%) 
present as simple FS [1]. Simple FS has good 
prognosis and is not linked to mortality, 
hemiplegia, or intellectual disability [5]. 
Generalized FS less than 15 min in duration and 
not repeated within 24 h are defined as simple 
FS [1,6]. However, although they are described 
as ‘simple,’ such seizures are nevertheless 
causes of grave anxiety for families [7].  
Iron serves as a cofactor for various enzymes in 
the body and is an important micronutrient 
involved in the synthesis of deoxyribonucleic 
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acid (DNA) and in the production of 
neurotransmitters and hormones. It is also an 
essential component of enzymes involved in a 
range of neurochemical reactions, such as 
myelin formation, brain energy metabolism, 
and neurotransmitter metabolism [8]. 
Numerous studies have shown that iron 
deficiency is associated with FS development 
in children [9,10]. Infants with iron deficiency 
are known to exhibit later cognitive, motor, 
social, emotional, and neurophysiological 
development than their peers, and studies have 
emphasized the importance of protecting the 
developing brain against iron deficiency [11]. 
This deficiency has been reported to cause poor 
physical performance through its role in muscle 
contraction and energy metabolism, and to lead 
to immune dysfunction due to its impact on the 
immune system [12]. This function impairment 
in the immune system can contribute to 
frequent fevers as a cause of increasing 
infections, and thus to more frequent FS.  
Vitamin B12 cannot be synthesized in the 
human body, but together with folic acid it 
plays a role in DNA synthesis, and cell division 
and proliferation. Deficiency is generally 
associated with insufficient intake in diet. It 
causes a wide spectrum of symptoms by 
affecting various systems.  
Described symptoms include growth and 
development delay, gastrointestinal motility 
disorders, hyperpigmentation, stomatitis, 
glossitis, orthostatic hypotension, tachycardia, 
irritability, lethargy, decreased activity, 
hypotonia, ataxia, hyporeflexia, tremor, 
seizure, movement disorders, vision disorders, 
loss of taste and smell, altered consciousness 
and memory, regression in acquired motor 
skills, paresthesia,  vibration and 
proprioception disorders, psychiatric disorders, 
and coma [13,14]. Although neurological 
disorders and seizures have been described with 
serum vitamin B12 and folic acid deficiency 
[15-17], the numbers of studies showing the 
relationship with FS are limited.  
Addressing treatable causes that may be 
involved in the etiology of FS can successfully 
prevent the disease. The purpose of the present 
study was to determine serum iron, ferritin, 
folate, and vitamin B12 deficiency and 
associated hemoglobin (Hb), hematocrit (Hct), 
mean corpuscular volume (MCV), and red cell 
distribution width (RDW) values in children 
undergoing FS, and thus to reveal their potential 
etiological role. 
 
Materials and methods 
The study was conducted at the Duzce 
University Faculty of Medicine Department of 
Pediatrics Division of Child Neurology, 
Turkey, between March 2019 and December 
2020. It was approved by the local ethics 
committee (2020/248). The study was 
conducted in accordance with the principles of 
the Declaration of Helsinki. All patients and the 
institution were informed about the study and 
their written consents were obtained.  
Ninety-eight patients and 64 healthy 
individuals as the control group identified 
retrospectively by scanning the hospital 
automation system were included in the study. 
Patients aged 1-60 months, with no previous 
history of afebrile seizure, with no history of 
trauma capable of resulting in seizure, in whom 
central nervous system infection and metabolic 
or electrolyte disorder were excluded, and with 
seizure induced only by fever were diagnosed 
with FS [3,4]. Generalized FS less than 15 min 
in duration and not recurring with 24 h was 
defined as simple FS [1,6]. Patients with FS 
attending the pediatric neurology clinic for 
routine controls at least two weeks after seizure 
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and at a time when no disease was present, and 
whose Hb, Hct, MCV, RDW, serum vitamin 
B12, folate, iron, and ferritin levels were 
investigated were included in the study. FS 
patients other than these 98 individuals, with 
insufficient available data, with histories of 
chronic disease or using vitamins were 
excluded from the study. The control group 
consisted of 64 children aged 1-60 months, 
attending the pediatric clinic for routine healthy 
child examination, whose Hb, Hct, MCV, 
RDW, serum vitamin B12, folate, iron, and 
ferritin levels were investigated, with no history 
of disease or malnutrition, and not receiving 
additional vitamin supplementation. FS group 
age and gender, history of FS and epilepsy in 
the family, parental consanguinity, type of 
delivery, birth week, history of hospitalization 
in the infant, degree of fever at time of seizure, 
presence of complicated or simple FS, body 
weight, electroencephalogram (EEG) results, 
antiseizure treatment requirements, 
neurological examination findings at time of 
seizure, and cranial magnetic resonance 
imaging (CMRI) results were recorded. The 
patient and control groups were compared in 
terms of age, gender, and Hb, Hct, MCV, RDW, 
serum vitamin B12, folate, iron, and ferritin 
levels. The patient group was subdivided into 
children with three or fewer 
simple/complicated seizures and those with 
more than three seizures, and the same 




Continuous data were expressed as mean ± SD 
(min-max), and categorical variables as 
frequency and percentage for each group. A 
range of statistical tests were applied, 
depending on normality of data distribution. 
The Kolmogorov-Smirnov test was used to 
determine the normality of distribution of the 
variables. The independent samples t-test was 
applied to normally distributed variables, while 
Pearson’s chi-square test and Fisher’s exact test 
were applied to categorical variables. The 
results were assessed within a 95% reliance and 
at a significance level of p <0.05. Analyses 
were performed on Statistical Package for 
Social Sciences 25.0 for Windows software 
(SPSS Inc., Chicago, IL, USA).  
 
Results  
The mean age of the patient group was 21±12 
months. Sixty-eight percent were boys and 32% 
girls. No family history of FS or epilepsy was 
present in 44% of the patients. A history of FS 
was present in 44.3% of families, of both FS 
and epilepsy in 6.2%, and of epilepsy in 5.2%. 
The parental consanguinity rate was 9.3%. 
Additionally, 79.2% of patients were born on 
term, 21.8% preterm, 64.9% by cesarean 
section, and 35.1% by the normal vaginal 
pathway. A history of hospitalization in the 
neonatal period was present in 17.5% of 
patients. In terms of body temperature, 35.1% 
of patients experienced seizures at 37-37.9°C, 
36.1% at 38-38.9°C, and 6.2% at more than 
39°C. Body temperature was unknown in 
22.7% of cases. FS was simple in 72.2% of 
patients, complex in 25.8%, and febrile status 
epilepticus in 2.1%. In addition, 83.5% patients 
were normal weight, 8.2% were overweight, 
and 8.2% were underweight. EEG was not 
performed on 29.9% of patients, while EEG 
results were normal in 44.3% and abnormal in 
25.8% (18.6% generalized, 7.2% focal 
abnormality). Results were normal in 21 of the 
22 patients on whom CMRI was performed, 
while dysgenesis of the corpus callosum 
splenium was determined in one. NO FS 
prophylaxis was being used by 52.6% of 
patients, 1.7% received intermittent 
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prophylaxis, and 29.9% were on continuous 
prophylaxis. Neurological examinations at time 
of seizure were normal in 97.6% of patients. 
The distribution of all patient group categories 
is shown in Table 1.  
The mean age of the control group was 26±14 
months, 33 (51.6%) were boys and 31 (49.4%) 
were girls. Age and gender distributions were 
similar between the two groups. Vitamin B12, 
iron and ferritin levels were significantly lower 
in the patient group compared to the control 
group.  No difference was observed between 
folate, Hb, Hct, MCV, or RDW values (Table 





























When the patient group was subdivided into 
individuals with three or fewer seizures (80 
patients) and those with more than three 
seizures, the only difference in the study 
parameters was observed in significantly higher 
RDW values among patients undergoing more 
than three seizures (Table 3). When the patient 
group was subdivided into simple and 
complicated FS, no significant difference was 
observed between the parameters, although 
RDW values were higher in the complicated FS 
group, but the difference was not statistically 






























Table 1. Demographic and clinical data of patients with febrile seizures. 
 
Variables N (%) or Mean±SD Variables N (%) or Mean±SD 
Age (month) 21±12 FS classification  
Gender     Basic FS 
   Complex FS 




   Female 
   Male 
66 (%68) 
31 (%32) 
Family history   Neurological examination  
   Absent 
   FC 
   Epilepsy 





   Normal 






Consanguinity       >97p 
   <3p 




   Absent 
   Present 
88 (90.7) 
9 (9.3) 
Delivery type  EEG result  
   C/S 
   Normal 
63 (64.9) 
34 (35.1) 
    
   Normal 
   Generalized abnormality 
   Focal abnormality 






Gestation week  
   Preterm 
   Term 
21 (21.8) 
76 (79.2) 
NICU history  CMRI result  
   Present  
   Absent 
17 (17.5) 
80 (82.5) 
   Normal 
   Abnormal 
    20 (20.6%) 
      2 (2.06%) 
Body temperature (°C)  n.a. Treatment      75 (77.3%) 
  Missing data 
  37-38 
  38-39 








   51 (52.6) 
   17 (17.5) 
    29 (29.9) 
FS: febrile seizure, C/S: cesarean section, NICU: newborn intensive care unit, EEG: electroencephalogram, CMRI: cranial 
magnetic resonance imaging, FSE: Febrile status epilepticus, n.a: not available. 
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FS is the most common form of childhood 
seizure [1]. Despite its high prevalence, the 
etiopathogenesis is complex and has not yet 
been fully explained. Numerous factors, 
including age, gender, infections, 
immunizations, cytokines, ethnicity, low 
calcium, sodium, iron, and zinc levels, 
microcytic anemia, progression to nursery 
school,  and a history of hospitalization 
exceeding 28 days in the neonatal period have 
all been implicated in the development of FS 
[1,18-23].  
Iron and ferritin levels in this research were 
significantly lower in the patient group than in 
the control group. Studies performed over many 
years have emphasized the association between 
low iron levels and iron deficiency anemia 
(IDA) and FS. In 1996, Pisacane et al. 
determined higher IDA in patients with FS 
compared to both a hospital group and the 
Table 2. A comparison of demographic 
characteristics and laboratory parameters between 








Age(months) 21±12 26±14 0.018a 
Gender 
  Male 
  Female 
  
0.047b 66(%68) 33(%51.6) 
31(%32) 31(%48.4) 
Vitamin B12 373±176 527±259 <0.001a 
Iron 49±26 65±22 <0.001a 
Ferritin 28±32 65±22 0.001a 
Folate 13.1±5.2 13.04±4.9 0.8a 
Hb 11.7±1.1 11.9±0.7 0.3a 
Hct 35±4 34±4 0.6a 
MCV 83±69 75±10 0.3a 
RDW 15.1±4.1 14.5±1.6 0.2a 
Hb: hemoglobin, Hct: hematocrit, MCV: mean 
corpuscular volume, RDW: red cell distribution width. 
Data expressed as n (%). Bold p values indicate 
statistical significance at α=0.05. 
a Independent samples t-test, b Pearson’s chi-square test.  
 
Table 3. The relationship between seizure 









Age(months) 21.9±12.6 16.6±11 0.1a 
Gender 
  Male  
  Female 
  
0.1b 52(65%) 14(82.6%) 
28(35%) 3(17.4%) 
Vitamin B12 362±162 427±226 0.16a 
Iron 26±23 47±28 0.8a 
Ferritin 26±23 38±57 0.14a 
Folate 13.1±5.2 11.04±4.9 0.13a 
Hb 11.7±1.1 11.6±1.7 0.5a 
Hct 35.1±4.3 35.7±3.6 0.6a 
MCV 85±75 75±4 0.5a 
RDW 14±1 18±9 <0.001a 
Hb: hemoglobin, Hct: hematocrit, MCV: mean 
corpuscular volume, RDW: red cell distribution width 
Data expressed as n (%). Bold p values indicate 
statistical significance at α=0.05 
a Independent samples t-test, b Pearson’s chi-square test.  
 
Table 4. Relationships between type of febrile 








Age(month) 22.1±12 18.6±9.8 0.23a 
Gender 
  Male 
  Female 
  
0.1b 52(74.3%) 13(52%) 
18(25.7%) 12(48%) 
Vitamin B12 370±180 370±176 0.96a 
Iron 49.5±30 49.7±30.5 0.9a 
Ferritin 22±16 41±54 0.01a 
Folate 12.1±4.2 13.9±6.4 0.3a 
Hb 11.7±1.2 11.6±0.9 0.6a 
Hct 35.2±4.4 35±3.6 0.8a 
MCV 86±81 77±5 0.5a 
RDW 14±1 16±7.8 0.08a 
Hb: hemoglobin, Hct: hematocrit, MCV: mean 
corpuscular volume, RDW: red cell distribution width, 
FS: febrile seizure. Data expressed as n (%). Bold p 
values indicate statistical significance. 
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normal population [10]. A case-control study 
from 2017 compared Hb, Hct, RDW, MCV, 
mean corpuscular hemoglobin (MCH), and 
mean corpuscular hemoglobin concentration 
(MCHC) values between a 30-member FS 
group and a non-febrile control group enrolled 
at the same time. All values in the case group 
were significantly in favor of anemia [24]. No 
difference was observed between our patient 
and control groups in terms of Hb, Hct, MCV, 
and RDW values. 
In their meta-analysis of 17 studies, Kwak et al. 
determined a high level of correlation between 
IDA and FS (OR, 1.98; 95% CI, 1.26–3.13; 
p=0.003). While MCV (OR, 2.08; 95% CI, 
1.36–3.17; p = 0.001) and plasma ferritin (OR, 
3.78; 95% CI, 1.80–7.94; p < 0.001) exhibited 
moderate correlation with FS in some 
comparisons, no relationship was determined in 
two studies involving serum iron (OR, 0.57; 
95% CI, 0.24–1.37; p = 0.210) [9].  
A rat study reported a low seizure threshold in 
mice exposed to iron deficiency in the postnatal 
period, and showed that those mice were more 
susceptible to some types of seizure [25]. The 
mechanisms by which iron deficiency leads to 
seizure by causing excitatory-inhibitor 
imbalance are not yet fully understood. 
A recent prospective study comparing 63 FS 
patients and a control group of 65 patients with 
nonconvulsive febrile illness reported 
significantly low serum iron, plasma ferritin, 
and transferrin saturation in the FS group. 
Consistent with the present study, iron 
deficiency was reported to increase the risk if 
FS even in the absence of IDA [26].  
However, there are also studies reporting either 
the opposite or else no relationship. Kobrinsky 
et al. reported that iron deficiency can play a 
protective role in the context of FS [27]. 
Soheilipoor et al. compared 158 children with 
FS and 149 febrile children without seizures in 
terms of Hb, Hct, RBC count, MCV, MCH, 
MCHC, values and weight for age. Greater IDA 
was observed in febrile children without 
seizures, while no association was found 
between growth delay and FS [28]. Since no 
low-weight control group was included in the 
present study, no comparison was performed 
with growth delay. We observed no association 
between our patients’ anemia-related values 
and those of the control group. In their meta-
analysis, Habibian et al. observed an increased 
prevalence of anemia in patients with FS. The 
authors determined a moderately increased risk 
of FS with IDA in societies in which anemia is 
less common, compared to those in which it is 
only seen at high levels [29].  
Serum vitamin B12 levels were significantly 
lower in the FS group than in the control group 
in the present study. However, there was no 
difference in serum folate levels between the 
two groups. The number of studies examining 
the relationship between serum vitamin B12 
and folate levels and FS is limited. Vitamin B12 
and folic acid serve on the methionine-
homocysteine pathway responsible for the 
provision of methyl groups essential for DNA 
and protein synthesis. Vitamin B12 catalyzed 
the formation of methionine from 
homocysteine and the conversion of 
methylmalonyl coenzyme A (MMA) to 
succinyl coenzyme A [30,31]. Although the 
exact role of vitamin B12 in epileptogenesis is 
unclear, various mechanisms have been 
proposed in the mechanism, including MMA 
accumulation due to deficiency leading to 
impairment in myelin synthesis [30], increased 
homocysteine contributing to neurological 
dysfunction by way of oxidative stress [30-32], 
a decreased S-adenosylmethionine/ S 
adenosylhomocysteine ratio compromising the 
methylation pathway [33], and the protective 
effect of S-adenosylmethionine against N-
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methyl aspartate receptor (NMDA)-mediated 
glutamate neurotoxicity [34]. 
Folate and cobalamin levels were investigated 
in both serum and cerebrospinal fluid (CSF) in 
40 febrile children (18 FS, 22 non-FS) and in 
serum in 20 healthy children. Serum folate 
levels were significantly higher in all patients 
compared to the healthy group, the highest 
values being determined in FS patients. No 
difference was found in CSF levels between the 
FS and non-seizure febrile patients. This was 
interpreted as indicating that even if folate 
levels are elevated in serum, passage to the 
brain is prevented by the blood-brain barrier, 
and it therefore exhibits no seizure-triggering. 
Patients’ serum cobalamin levels were lower 
than in the control group, while no difference 
was observed between the FS patients and the 
febrile non-seizure patients, and no association 
with FS could be established [35].   
Similarly to the present study, Özkale et al. 
determined lower vitamin B12 levels in an FS 
group compared to a seizure-free group, while 
no difference was observed between the two 
groups in terms of serum folate, homocysteine, 
Hb, MCV, macrocytosis, or anemia. Folic acid 
levels were also lower among patients in the FS 
group with more than three seizures and in 
those experiencing seizures at a temperature 
range of 37.5-39°.  The authors associated 
vitamin B12 deficiency with an increased 
disposition to FS, and folic acid deficiency with 
an increased frequency of FS [36].  
When patients with FS frequencies of three or 
fewer were compared with those with 
frequencies of more than three, RDW values 
were significantly higher in the latter group. 
When our FS patients were divided into simple 
and complex seizures, no difference was 
determined between any parameters. RDW 
values were higher in the complicated group, 
but not significantly so. Considering that RDW 
values will naturally rise in case of iron, vitamin 
B12 and folate deficiency, elevation in RDW 
values in children undergoing frequent seizures 
may be useful in predicting vitamin B12, folate 
and iron deficiencies. In addition, the absence 
of significance among other parameters at 
intergroup comparison among the FS patients 
may be due to the unequal numbers in patient 
distribution. 
The principal limitation of this study is its 
retrospective nature. We were therefore unable 
to evaluate parameters such as homocysteine, 
methylmalonic acid, transferrin saturation, and 
iron binding capacity. Our case number may 
also be regarded as insufficient in the light of 
the incidence of FS in the general community. 
However, anemia evaluation and serum iron, 
ferritin, folic acid, and vitamin B12 
measurement are not routinely recommended in 
children presenting with FS. Considering that 
patients in which all parameters were fully 
examined were included in the study, the 
number is adequate.  
  
Conclusions 
The present study is the first study which 
investigates the relationship between Hb, Hct, 
MCV, RDW parameters and iron, vitamin B12, 
folate deficiencies with FS. Our findings show 
that although low serum ferritin, iron, and 
vitamin B12 levels do not cause anemia, they 
can increase the tendency to FS. We 
recommend that iron and vitamin B12 be 
examined in FS patients with RDW elevation 
due to the possibility of frequent seizure 
recurrence. Since the etiology of FS is 
multifactorial, the treatment of iron and vitamin 
B12 deficiencies may be effective in reducing 
the development of FS. Further prospective 
studies involving large case numbers are now 
needed in order to identify the mechanisms 
involved in FS development.  
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